Free shipping on all orders over $ 500

IL Receptor/Related Interleukin Receptor/Related

Cat.No.  Name Information
M6189 Ossirene Ossirene (AS101), a potent in vitro and in vivo immunomodulator, is a novel inhibitor of IL-1beta (IL-1β) converting enzyme. Ossirene abolishes phosphorylation of STAT3 by inhibiting IL-10. Ossirene also inhibits Caspase-1.
M6223 Tocilizumab Tocilizumab is a humanized monoclonal antibody that binds to the interleukin-6 receptor. Tocilizumab prevents binding of IL-6 to the IL-6R, thereby inhibiting both classic and trans-signaling. Tocilizumab can be used for the research of rheumatoid arthritis and COVID-19.
M10139 Anakinra Anakinra (Raleukin) is an antagonist of recombinant, nonglycosylated human IL-1R.
M1622 Secukinumab Secukinumab (AIN457) is a high-affinity monoclonal antibody against interleukin (IL-17A). Secukinumab (AIN457) is the first-in-class anti-IL-17 agent to be used in studies of plaque psoriasis, ankylosing spondylitis, and psoriatic arthritis.
M59155 RS17 RS17 is an anti-tumor peptide designed to bind specifically to the CD47 molecule and block the interaction between CD47 and its ligand, SIRPα, on the surface membrane of macrophages.
M58640 IL-17A modulator-2 IL-17A modulator-2 is a IL-17A modulator. IL-17A modulator-2 inhibits the biological action of IL-17A with a pIC50 of 8.3. IL-17A modulator-2 can be used for the research of diseases associated with modulation of IL-17A activity.
M56367 IL-15-IN-1  IL-15-IN-1 is a potent and selective Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells with an IC50 of 0.8 μM.
M56366 IL-17 modulator 3  IL-17 modulator 3 is an IL-17 modulator.
M56364 IL-17A modulator-3  IL-17A modulator-3 is a IL-17A modulator.
M56363 IL-17 modulator 4 sulfate  IL-17 modulator 4 sulfate is a proagent of IL-17 modulator 1.
M55322 LY3471851 LY3471851 (Rezpegaldesleukin, NKTR-358) is a novel, first-in-class selective regulatory T-cell (Treg) inducing IL-2 conjugate.
M54690 HB0017 HB0017 is a monoclonal antibody that targets interleukin-17 (IL-17) and selectively binds IL-17A, thereby preventing IL-1717A from binding to its receptor.
M54550 Stapokibart Stapokibart is a humanized monoclonal antibody targeting IL-4Rα that blocks the interaction of cytokines IL-4 and IL-13 with their co-receptor subunit, IL-4Rα. Stapokibart is able to interact with IL-4Rα in humans, cynomolgus monkeys, and rats, and can be used in atopic dermatitis research.
M52856 Antiflammin-1 Antiflammin-1 is an anti-inflammatory peptide 1 (MQMKKVLDS).
M52855 β-Interleukin II (44-56) β-Interleukin II (44-56) is a 44-56 fragment of beta-interleukin II polypeptide.
M52854 Interleukin II (60-70) Interleukin II (60-70) is a 60-70 fragment of the cytokine Interleukin II polypeptide.
M52853 Acetyl hexapeptide-49 Acetyl hexapeptide-49 is a bioactive peptide with anti-allergen effect and has been reported used as a cosmetic ingredient.
M52852 Myelopeptide-2 Myelopeptide-2 is a peptide which can restore mitogenic reactivity of human T lymphocytes inhibited by HL-60 leukemia cells or measles virus conditions.
M52851 Romurtide Romurtide (Muroctasin), a synthetic muramyl dipeptide derivative, is a cytokines inducer.
M52850 YVAD-CHO YVAD-CHO is an interleukin-1β converting enzyme (ICE, caspase 1) inhibitor that can partially delay motoneurone death in lesioned facial nerve mice.
M52849 Lib2-1 Lib2-1, a macrocyclic peptide, is an IL-17C/IL-17RE interaction inhibitor.
M52817 [D-Arg1, D-Phe5, D-Trp7, 9, Leu11]-Substance P [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P, a Substance P derivative, is a biased agonist toward neuropeptide and chemokine receptors.
M49645 Balsalazide sodium hydrate Balsalazide sodium hydrate could suppress colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway.
M49455 CALY-002 CALY-002 is a potential best-in-class (BIC), humanized monoclonal antibody targeting IL-15 for studies related to immune diseases.




Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.